<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 17.6: The Gut-Brain-Immune Axis in Neuroinflammation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #064e3b 0%, #059669 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a1a1a;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #059669;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #064e3b 0%, #059669 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 5px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #064e3b;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #065f46;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 13px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 17: Complex Client Scenarios</p>
            <h1 class="lesson-title">Lesson 6: The Gut-Brain-Immune Axis in Neuroinflammation</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Advanced Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#leaky-brain"><span class="section-num">1</span>The Leaky Gut, Leaky Brain Connection</a></li>
                <li><a href="#microbiome-patterns"><span class="section-num">2</span>Patterns in Neurodegeneration</a></li>
                <li><a href="#microglia-scfas"><span class="section-num">3</span>SCFAs and Microglia Regulation</a></li>
                <li><a href="#tryptophan"><span class="section-num">4</span>The Kynurenine Pathway Shunt</a></li>
                <li><a href="#vagus-nerve"><span class="section-num">5</span>Vagus Nerve Stimulation (VNS)</a></li>
                <li><a href="#clinical-application"><span class="section-num">6</span>The Method: Neuro-Recovery</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the molecular mechanisms by which <span class="highlight">Zonulin and LPS</span> compromise the Blood-Brain Barrier (BBB).</li>
                <li>Identify microbial signatures associated with Parkinson‚Äôs, Multiple Sclerosis, and chronic neuroinflammation.</li>
                <li>Explain the role of Short-Chain Fatty Acids (SCFAs) as <span class="highlight">epigenetic regulators</span> of brain-resident immune cells (microglia).</li>
                <li>Analyze the Tryptophan-Kynurenine pathway and how gut dysbiosis drives neurotoxicity.</li>
                <li>Implement non-invasive Vagus Nerve Stimulation techniques to restore gastro-neurological tone.</li>
            </ul>
        </div>

        <h2 id="leaky-brain">1. The 'Leaky Gut, Leaky Brain' Connection</h2>
        <p>In the previous lessons, we explored how environmental toxins (L5) and viral sequelae (L4) can damage the intestinal barrier. However, for the complex client presenting with cognitive decline, severe brain fog, or motor dysfunction, we must look beyond the gut. The concept of <span class="highlight">"Leaky Brain"</span>‚Äîor increased Blood-Brain Barrier (BBB) permeability‚Äîis now recognized as a critical parallel to intestinal permeability.</p>

        <p>The BBB is a highly selective semi-permeable border of endothelial cells that protects the brain from circulating toxins and pathogens. Crucially, the same proteins that maintain the gut barrier‚Äî<span class="highlight">Occludin and Claudin-5</span>‚Äîare also the primary components of the BBB's tight junctions. When a client experiences chronic metabolic endotoxemia (the presence of LPS in the blood), the systemic inflammatory response triggers the release of <strong>Zonulin</strong> not just in the gut, but systemically.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">3x</span>
                    <span class="stat-label">Higher LPS in AD Brains</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">82%</span>
                    <span class="stat-label">BBB Leakage in CFS</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">0.45</span>
                    <span class="stat-label">Correlation: Gut/BBB Leak</span>
                </div>
            </div>
        </div>

        <p>A <span class="stat-highlight">2021 study published in <i>Nature Communications</i></span> demonstrated that LPS can directly bind to TLR4 receptors on the BBB, leading to a "loosening" of the junctions. This allows pro-inflammatory cytokines (IL-6, TNF-alpha) and environmental toxins to enter the central nervous system (CNS), effectively turning a "gut problem" into a "brain fire."</p>

        <h2 id="microbiome-patterns">2. Microbiome Patterns in Neurodegeneration</h2>
        <p>While we avoid "one-bug-one-disease" thinking in <i>The Method</i>, research has identified consistent microbial "landscapes" in neuroinflammatory conditions. These patterns often precede clinical diagnosis by years, particularly in Parkinson‚Äôs Disease (PD).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Condition</th>
                        <th>Associated Microbial Shift</th>
                        <th>Mechanism of Action</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Parkinson‚Äôs Disease</strong></td>
                        <td>‚Üì <i>Prevotellaceae</i>; ‚Üë <i>Akkermansia</i> (distal)</td>
                        <td>Alpha-synuclein aggregation in the ENS via Vagus Nerve.</td>
                    </tr>
                    <tr>
                        <td><strong>Multiple Sclerosis</strong></td>
                        <td>‚Üì <i>Faecalibacterium prausnitzii</i>; ‚Üë <i>Acinetobacter</i></td>
                        <td>Loss of Treg induction; increased Th17 pro-inflammatory activity.</td>
                    </tr>
                    <tr>
                        <td><strong>Alzheimer‚Äôs Disease</strong></td>
                        <td>‚Üë <i>Bacteroidetes</i>; ‚Üì <i>Firmicutes</i></td>
                        <td>Increased LPS production leading to amyloid plaque formation.</td>
                    </tr>
                    <tr>
                        <td><strong>Severe Brain Fog</strong></td>
                        <td>‚Üë <i>Streptococcus</i> & <i>Enterococcus</i></td>
                        <td>D-lactic acid production and excessive ammonia levels.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>In Parkinson's, the <span class="highlight">"Braak Hypothesis"</span> suggests that the pathology begins in the gut. Pathogenic bacteria trigger the misfolding of alpha-synuclein proteins in the Enteric Nervous System (ENS), which then travel like a "prion-like" infection up the Vagus Nerve to the brainstem. This underscores why addressing motility and the microbiome is non-negotiable for neuro-protection.</p>

        <h2 id="microglia-scfas">3. SCFAs as Epigenetic Regulators of Microglia</h2>
        <p>Microglia are the resident immune cells of the brain. In a healthy state, they are "homeostatic," acting as gardeners that prune synapses and clear debris. However, in neuroinflammation, they become <span class="highlight">"Primed" or "Reactive."</span> Reactive microglia release neurotoxic substances that kill neurons.</p>

        <p>Short-Chain Fatty Acids (SCFAs), particularly <strong>Butyrate</strong>, act as the primary "off-switch" for microglial over-activation. Butyrate functions as a <strong>Histone Deacetylase (HDAC) inhibitor</strong>. By inhibiting HDACs, butyrate promotes the expression of anti-inflammatory genes and suppresses the NF-kB pathway within the brain.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üß†</div>
                <div>
                    <p class="box-label">Case Study: The "Fading" Executive</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size: 13px;">Neuroinflammation & Cognitive Decline</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 54</h4>
                        <p>Symptoms: Severe brain fog, word-finding difficulty, chronic constipation, "vibrating" sensation in limbs.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Elena‚Äôs GI-MAP showed undetectable <i>Faecalibacterium prausnitzii</i> (the primary butyrate producer) and high secretory IgA, indicating chronic mucosal irritation. Her Serum Zonulin was significantly elevated (84 ng/mL).</p>
                <p><strong>Intervention:</strong> Instead of high-dose antimicrobials, we focused on <strong>BBB Support & SCFA Restoration</strong>:</p>
                <ul>
                    <li>Tributyrin supplementation (300mg 3x/day) to bypass primary colon usage and reach systemic circulation.</li>
                    <li>High-dose polyphenols (Luteolin and Baicalin) to stabilize microglial activation.</li>
                    <li>Vagus nerve exercises (gargling and cold face immersion).</li>
                </ul>
                <p><strong>Outcome:</strong> By week 12, Elena reported a "lifting of the veil." Her MoCA (Montreal Cognitive Assessment) score improved from 23 to 28. Her constipation resolved, correlating with improved neurological "top-down" signaling.</p>
            </div>
        </div>

        <h2 id="tryptophan">4. The Tryptophan-Kynurenine Pathway Shunt</h2>
        <p>A common mistake in gut coaching is assuming that low serotonin in the brain is simply due to low dietary tryptophan. In neuroinflammatory states, the body undergoes what is known as the <span class="highlight">"Kynurenine Shunt."</span></p>

        <p>When the gut is inflamed or LPS is high, an enzyme called <strong>Indoleamine 2,3-dioxygenase (IDO-1)</strong> is activated. IDO-1 "steals" tryptophan away from the Serotonin/Melatonin pathway and shunts it into the Kynurenine pathway. This results in two possible metabolites:</p>
        <ol>
            <li><strong>Kynurenic Acid (KYNA):</strong> Generally neuroprotective but can cause cognitive dulling in excess.</li>
            <li><strong>Quinolinic Acid (QUIN):</strong> Highly neurotoxic. It acts as an NMDA receptor agonist, literally "exciting neurons to death" (excitotoxicity).</li>
        </ol>

        <p>Dysbiotic bacteria (specifically <i>Pseudomonas</i> and certain <i>Bacillus</i> species) can further stimulate this shunt. As a practitioner, if you see a client with high anxiety, insomnia, and gut issues, simply giving 5-HTP may fail if the IDO-1 enzyme is overactive, as you may just be feeding the "neurotoxic fire."</p>

        <h2 id="vagus-nerve">5. Vagus Nerve Stimulation (VNS) for Gastro-Neurological Tone</h2>
        <p>The Vagus Nerve (Cranial Nerve X) is the physical substrate of the gut-brain axis. It is 80% afferent (sensing gut status and reporting to the brain) and 20% efferent (sending "rest and digest" signals to the gut). In chronic neuroinflammation, the "Vagal Tone" is often low, leading to poor MMC function, SIBO recurrence, and a "leaky" immune system.</p>

        <p><strong>Clinical Techniques to Improve Vagal Tone:</strong></p>
        <div class="principle-card">
            <div class="principle-title">Gargling to Fatigue</div>
            <div class="principle-text">The Vagus nerve innervates the muscles of the throat. Vigorous gargling (until tears form) activates the glossopharyngeal and vagus nerves, stimulating the "anti-inflammatory reflex."</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">Cold Thermogenesis</div>
            <div class="principle-text">Brief (30-60 second) cold exposure to the face or neck activates the mammalian dive reflex, which immediately increases vagal outflow and lowers heart rate.</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">Humming & Chanting</div>
            <div class="principle-text">Low-frequency vibrations in the vocal cords stimulate the auricular branch of the Vagus nerve. This is why "Om" chanting and rhythmic humming have measurable physiological effects on gut motility.</div>
        </div>

        <h2 id="clinical-application">6. The Method: Integrating Neuro-Recovery</h2>
        <p>When applying <i>The Method</i> to neuroinflammatory cases, the order of operations shifts. While we still use the 5R framework, we must prioritize <strong>Stabilization</strong> of the BBB and Microglia before aggressive microbial "killing" protocols. Rapidly killing bacteria releases a surge of LPS (Herxheimer reaction), which can cross a leaky BBB and exacerbate neurological symptoms.</p>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Note: The "Brain-First" Rule</p>
            <p>If a client experiences neurological worsening (dizziness, increased tremors, severe depression) during a gut protocol, <strong>STOP</strong>. This is a sign that their BBB is compromised and the "detox" load is hitting the CNS. Pivot to BBB support (Luteolin, Butyrate, Collagen) for 4 weeks before resuming gut work.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why is high-dose Butyrate considered an "epigenetic" intervention for the brain?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Butyrate acts as a Histone Deacetylase (HDAC) inhibitor. This means it changes which genes are "turned on" or "off" in the brain, specifically silencing pro-inflammatory genes in the microglia and promoting neuroplasticity via BDNF (Brain-Derived Neurotrophic Factor).</p>
            </div>
            <div class="question-item">
                <p class="question-text">How does the "Kynurenine Shunt" explain why some gut clients don't respond to tryptophan/serotonin support?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">In the presence of inflammation (LPS), the IDO-1 enzyme diverts tryptophan away from serotonin production and into the Kynurenine pathway, creating neurotoxic Quinolinic Acid. Until the inflammation is lowered, adding tryptophan may simply increase neurotoxic metabolites rather than serotonin.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The gut and brain barriers share the same architecture; a "leaky gut" is highly predictive of a "leaky brain."</li>
                <li>LPS is a primary driver of neuroinflammation by activating TLR4 receptors on the Blood-Brain Barrier.</li>
                <li>Butyrate is a critical systemic signaling molecule that "calms" reactive microglia in the CNS.</li>
                <li>The Vagus Nerve is the "Anti-Inflammatory Reflex" arc; tone must be manually restored in complex cases.</li>
                <li>Stabilize the BBB and Microglia <i>before</i> attempting aggressive microbial clearance in neuro-compromised clients.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Cryan, J. F., et al. (2019). "The Microbiota-Gut-Brain Axis." <i>Physiological Reviews</i>.</li>
                <li>Pellegrini, C., et al. (2021). "Gut-brain axis and Parkinson‚Äôs disease: focus on neuroinflammation." <i>Journal of Neuroinflammation</i>.</li>
                <li>Vancamelbeke, M., & Vermeire, S. (2017). "The intestinal barrier: a fundamental role in health and disease." <i>Expert Review of Gastroenterology & Hepatology</i>.</li>
                <li>Rhea, E. M., et al. (2020). "The Blood-Brain Barrier in Health and Disease." <i>Nature Reviews Neurology</i>.</li>
                <li>Kennedy, P. J., et al. (2017). "Kynurenine pathway metabolism and the microbiota-gut-brain axis." <i>Neuropharmacology</i>.</li>
                <li>Bonaz, B., et al. (2018). "The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis." <i>Frontiers in Neuroscience</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>